Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study

  • Read more about COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study

COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study

  • Read more about COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study

Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms

  • Read more about Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms

SINUS WASH Pilot Study in Adults Testing Positive for COVID-19

  • Read more about SINUS WASH Pilot Study in Adults Testing Positive for COVID-19

Trial of Imatinib for Hospitalized Adults With COVID-19

  • Read more about Trial of Imatinib for Hospitalized Adults With COVID-19

COVID-19 and Cancer Patients

  • Read more about COVID-19 and Cancer Patients

First Level Socio-geriatric Evaluation: ESOGER Databank

  • Read more about First Level Socio-geriatric Evaluation: ESOGER Databank

An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

  • Read more about An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

The Professional Peer Resilience Initiative

  • Read more about The Professional Peer Resilience Initiative

Risk of Air Contamination During Visceral Surgery in COVID19 Patients

  • Read more about Risk of Air Contamination During Visceral Surgery in COVID19 Patients

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 248
  • Page 249
  • Page 250
  • Page 251
  • Current page 252
  • Page 253
  • Page 254
  • Page 255
  • Page 256
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA